Blackboard
   Expand   Collapse                             Search

Show details for 20142014
Hide details for 20152015
Show details for 0101
Show details for 0202
Show details for 0303
Show details for 0404
Show details for 0505
Show details for 0606
Show details for 0707
Show details for 0808
Show details for 0909
Hide details for 1010
10/26/201502:09 PMEMD Millipore Introduces Parteck® SRP 80 Excipient for Sustained-Release Oral Solid Dose FormulationsEMD_Millipore_Parteck_SRP_80_Release_FINAL.pdf PR_Visual_Parteck_SRP_80_FINAL_ENG.jpg
10/22/201508:58 AMEMD Millipore to Provide Provantage® End-to-End Solution for Development and Manufacture of Biosimilars under Strategic Alliance with Turgut IlaçEMD_Millipore_Turgut_PR_FINAL.pdf
10/21/201508:55 AMEMD Millipore Introduces Millipore Express® PHF Hydrophilic Sterilizing-Grade Filters for Fast, Efficient and Economical Buffer FiltrationEMD_Millipore_Express_PHF_Release_final.pdf
10/21/201502:00 PMMerck KGaA, Darmstadt, Germany, Presents First Curiosity Report in the U.S. to Help Drive InnovationBuilding_in_New_York.jpg 125_Years_Press_release_EMD.pdf
10/20/201512:00 PMMerck KGaA, Darmstadt, Germany, Announces Sigma-Aldrich Business Sale to Honeywell to Fulfill EU CommitmentsPM_20102015_US.pdf Mercrobe_man_v1.jpg
10/14/201509:00 AMMerck KGaA, Darmstadt, Germany, launches new brandingvibrantM_4C_5.jpg vibrantM_4C_4.jpg vibrantM_4C_3.jpg vibrantM_4C_2.jpg vibrantM_4C_1.jpg Brand-USII.pdf
10/13/201501:30 PMStefan Oschmann Appointed New Executive Board Chairman of Merck KGaA, Darmstadt, GermanyStefanOschmann.jpg CEO-Wechsel_US.pdf
10/07/201501:00 PMMerck KGaA, Darmstadt, Germany, and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Designation for Metastatic Merkel Cell CarcinomaHome-Carousel-2.jpg FastTrackFDA_US.pdf
10/01/201509:30 AMMerck KGaA, Darmstadt, Germany, Agrees to Return Kuvan Rights to BioMarin Pharmaceutical to Strengthen Focus on Core BusinessPack_Kuvan.jpg BioMarin_US.pdf
10/01/201510:00 AMMerck KGaA, Darmstadt, Germany, Creates Greater Scope for Developing Ideas – Innovation Center openedfinalInnovationCenter-from2018on.jpg InnovationCenter2-opened1Oct2015.jpg InnovationCenter-openend1Oct2015.jpg OpeningEvent-US.pdf
10/01/201511:00 AMMerck KGaA, Darmstadt, Germany, Presents Details on Immuno-Oncology Program Including First-in-Man Milestone with Investigational Bi-Functional ImmunotherapyMedia-main.jpg Oct1_RD_update_US.pdf
Show details for 1111
Show details for 1212
Show details for 20162016
Show details for 20172017
Show details for 20182018


   Expand   Collapse                             Search

© Merck KGaA, Darmstadt, Germany